Guardant Health, Inc.
GENE MUTATIONS AND COPY NUMBER ALTERATIONS OF EGFR, KRAS AND MET

Last updated:

Abstract:

Sequence variants and copy number variations in the EGFR, KRAS and MET genes are biomarkers for resistance to anti-EGFR therapies for cancer. This disclosure provides methods of detecting these biomarkers and using them in the diagnosis and treatment of cancer.

Status:
Application
Type:

Utility

Filling date:

4 Mar 2019

Issue date:

22 Aug 2019